Should the Eye Exam Be Separated From the Spectacle Sale?
A reader left a comment on our last piece that deserved more than a reply box. They asked whether it was time to seriously consider separating the eye examination from the retail sale of eyewear — not refraction from the eye exam, but the clinical appointment from the spectacle transaction. And whether optometrists could simply operate as standalone clinical practitioners, no dispensing, no frame wall, no retail overhead. It is a question the profession keeps circling without ever quite landing on. This is worth a proper look.
The comment also raised something that does not get nearly enough airtime. Dispensing opticians are caught in the same structural trap as optometrists. Clinical expertise, patient relationships, years of training — rewarded with employment terms that do not reflect the value being delivered, inside a retail model that was not designed with them in mind either. Any serious conversation about restructuring how eye care is delivered in the UK has to include dispensing opticians. They are not a footnote to this debate.
What we are actually talking about — and what we are not.
Let us be precise about the proposition, because it matters. The question is not whether refraction should be separated from the eye examination. The GOC ran a full call for evidence on the Opticians Act in 2022, which included exactly that question. The profession responded clearly, and in 2023 the GOC concluded that dispensing opticians should not be permitted to perform refractometry for the sight test. Refraction and eye health examination are clinically intertwined — subtle changes in a patient's refraction can be the first signal of asymptomatic disease, and the AOP estimated that around 20% of patients may have ocular pathology that would go undetected if the two were separated. The GOC also committed to a broader programme of business regulation reform — extending regulation to all businesses carrying out restricted optical functions — but that requires changes to the Opticians Act itself, which in turn requires Parliamentary action. As of 2026, that legislation has not yet been passed. The reform programme remains live and incomplete.
That is not the argument here. The argument is different. The question is whether the clinical encounter — the full, integrated eye examination, including refraction and health assessment — needs to take place in a retail optical practice at all. Whether the sale of spectacles needs to happen in the same building, from the same organisation, as part of the same transaction. That is a structural and commercial question, not a clinical one. And it is a question the 2022 consultation did not address. It has never been formally consulted on. And it is a question several other countries have answered very differently from the UK.
What other countries actually do.
The UK's model — in which registered optometrists conduct eye examinations and registered dispensing opticians handle the supply of appliances, as two distinct professions operating largely within the same retail premises — is genuinely unusual in a European context. According to data from the European Council of Optometry and Optics (ECOO), the UK has the largest optometric workforce in the EU. But the comparison gets more interesting from there.
France, for a population of 64 million, has approximately 2,000 optometrists — but around 25,000 opticians. The title 'optometrist' is not formally recognised by law in France, and eye examination functions that are routine in the UK are either restricted or reserved for ophthalmologists. In Germany, similarly, the optometrist title carries no formal legal status, and the primary care structure relies on a combination of ophthalmologists and dispensing opticians. Spain takes a different route again: optometry and dispensing are treated as a single combined profession, which partly explains why Spain records a higher number of optometrists per head of population than the UK — they are counting a merged professional category.
In Denmark and the Netherlands, optometrists are recognised as a professional category, and in some of those systems, they operate with greater clinical independence. The published survey data on variation in eye care professional distribution across Europe confirms just how different the structures are country to country — and how much variation there is in what optometrists are permitted to do.
In the United States, Doctors of Optometry are defined as physicians by the Centers for Medicare and Medicaid Services and can bill insurance accordingly. The regulatory framework permits optometrists to operate as standalone clinical practitioners with no retail attached — and many do, running examination-only practices that refer patients elsewhere for their spectacles, a model that has existed for decades alongside the more common retail-attached practice. Whether that model is straightforwardly transplantable to the NHS context is a different question. But it demonstrates that the combination of eye examination and spectacle retail within a single commercial transaction is not an immutable law of nature. It is a structural choice the UK made.
The solo optometrist model: pure examination, no retail.
Could a UK optometrist operate as a pure clinical practitioner — one room, one chair, one consulting diary, no framed wall, no dispensing staff, no retail operation? The clinical framework already exists to support something close to this. Independent prescribing optometrists can now manage a wide range of ocular conditions without referral to secondary care. In Wales, the IP optometrist service demonstrated that 92% of patients attending could be managed without onward referral to hospital — bringing immediate benefits to patients, GP practices, and the hospital eye service simultaneously.
An optometrist operating from a room inside a GP surgery or primary care network building, conducting NHS and private eye examinations, writing prescriptions that patients then take wherever they choose to have their spectacles dispensed — this is not a fantasy. The clinical competence is there. The referral pathway infrastructure is developing. This is worth pausing on, because the NHS already separates examination from dispensing at the transaction level. A patient's GOS optical voucher is theirs to take wherever they choose — there is no obligation to redeem it at the practice that conducted the sight test. The separation the reader is calling for already exists in principle within the NHS framework. What does not exist is the commissioning and contracting infrastructure to make a standalone examination-only NHS practice financially viable — the GOS sight test fee, at £24.13 and documented as less than 50% of the true cost of delivery, has always assumed that retail dispensing revenue would subsidise the clinical work. Strip out the retail, and the NHS examination fee alone does not sustain a practice. That is the structural problem. Not the law. Not the voucher system. The fee.
The financial case for the model is also more credible than it might appear, particularly once the revenue picture extends beyond the NHS sight test fee. A standalone clinical practice built on a mixed private and NHS examination base, supplemented by specialist services, starts to look viable in a way that an NHS-only examination room does not. Consider what a well-positioned single-practitioner clinical practice could reasonably offer:
Dry eye clinics. Dry eye disease is one of the most prevalent ocular conditions in the UK, and patient demand for dedicated assessment and management far outstrips what a standard 20-minute NHS sight test can address. Private dry eye clinics — involving detailed anterior segment assessment, meibomian gland evaluation, and ongoing management — are an established and growing revenue stream for independent practices and translate naturally to a clinical-only setting with no retail dependency.
Glaucoma monitoring and management. With around 600,000 people on the NHS ophthalmology waiting list, the pressure on secondary care glaucoma services is severe. IP optometrists are already providing community glaucoma monitoring in various commissioned pathways. A standalone clinical practitioner with IP qualifications, operating on referral from GPs or ophthalmologists, directly fills this gap.
Visual stress assessment and colourimetry. Visual stress — sometimes referred to as Meares-Irlen syndrome — is estimated to affect a significant proportion of the population, with particular prevalence among those with dyslexia and related conditions. Colourimetry assessment using an Intuitive Colorimeter is already offered as a private specialist service by many independent practices and sits entirely outside the NHS sight test. The assessment itself is the clinical product. It is worth noting that precision tinted spectacle lenses — the treatment that follows a positive assessment — do require dispensing in the same way as any prescription spectacles, and the College of Optometrists advises that the evidence base for tinted lenses in this area is still developing. Practitioners should represent this accurately to patients. A standalone clinical practitioner offering colourimetry assessment could refer patients elsewhere for tinted lens dispensing, or partner with a dispensing practice to complete the pathway.
Occupational and vocational vision assessment. Driving licence visual standards reports, workplace visual requirements assessments, pilot and vocational medical vision reports — these are documented, fee-generating clinical services with clear demand, no NHS dependency, and no connection to the retail sale of spectacles whatsoever. They are exactly the kind of work that a standalone clinical practitioner, operating as a healthcare professional rather than a retailer, is well placed to provide.
None of these services requires a frame wall. None requires dispensing staff. Most require only a well-equipped consulting room, the right qualifications, and a clear referral network. The one-person clinical practice is not a compromised version of a "proper" optical business. It may simply be a different — and in some markets, more sustainable — model entirely.
Take it a step further. A single optometrist. A small unit on a high street — the kind of space a solicitor or an accountant occupies. No NHS contract. No retail overhead. No staff. Private examination fees only, supplemented by the specialist services above. The overheads of such a practice are a fraction of a conventional optical unit: no frame stock, no stock write-offs, no lab accounts, no dispensing staff payroll. The practitioner's time is entirely clinical. Every hour is a consulting hour. Patients come for an examination, leave with a prescription, and take it wherever they choose.
Is this model viable everywhere? Almost certainly not. In some markets, patients will not pay a private fee for an examination they expect to receive for free, or cross-subsidised through spectacle purchase. Access is a genuine concern — a purely private model excludes patients who cannot afford private fees, and that matters. The NHS GOS contract provides a guaranteed income floor that abandoning it removes entirely. Building a referral network from scratch takes time that employed optometrists trading into independence do not have in abundance at the start.
These are real drawbacks. They belong in the conversation. But so does this: the current model — an NHS sight test at £24.13, with the profession's own negotiating body stating it represents less than 50% of the true cost of delivery, cross-subsidised by spectacle retail in a race-to-the-bottom market — is also not working. The status quo has its own risks. They are just more familiar, and familiarity gets mistaken for safety.
The clinical practice already exists inside the retail shell.
Here is what is easy to miss in this debate: for a growing number of optometrists, the separation is already happening in everything but name. An optometrist running Minor Eye Conditions Service (MECS) or Community Urgent Eyecare Service (CUES) appointments is operating as a pure clinical practitioner for those sessions. No spectacle sale. No frame choice. A clinical encounter, a clinical decision, a clinical outcome — contracted and commissioned separately from the GOS sight test and from the retail operation running in the same building. An IP optometrist managing patients discharged from the hospital eye service back to community care is not functioning as a spectacle retailer. Neither is the optometrist running a commissioned glaucoma monitoring clinic, nor conducting pre-operative assessments for cataract patients, nor triaging urgent referrals that would otherwise join the approximately 600,000-person ophthalmology waiting list. These are clinical services. The frame wall in the background does not define them.
Wales has gone furthest in formalising this. The WGOS contract reform, introduced in October 2023, created five distinct levels of commissioned clinical service — from core sight testing through to independent prescribing for complex conditions — each with its own fee structure and clinical governance framework. The most experienced clinical practitioners in Wales now spend a material portion of their working week functioning as pure clinicians. The retail operation remains, but it is no longer the load-bearing structure. Scotland has comparable enhanced service pathways. England's picture is patchier — MECS and CUES provision is inconsistent across ICB areas, and the commissioning infrastructure, while real, is fragmented. But the direction of travel is clear, and the clinical capability is already there.
The question this article is really asking is not whether optometrists can operate as standalone clinical practitioners. They already are, in fragments, in commissioned sessions, and in buildings that also sell frames. The question is whether an independent practitioner can build a practice around the clinical work — making it the commercial foundation rather than the cross-subsidised add-on — and whether the commissioning, contracting and patient systems will eventually catch up with that model. That question is about architecture. And as the next section shows, the market is already starting to answer it from the other direction.
The dentistry question.
The reader's comment also invoked the dental comparison. It is a fair one, and it deserves careful handling, because the NHS dental collapse is also a cautionary tale, not just a template for collective action. The Nuffield Trust has concluded that universal access to NHS dentistry has likely gone for good — a system that deteriorated slowly and then all at once, as dentists left NHS contracts for private practice in growing numbers because the financial maths stopped working. The NHS sight test fee in England is currently £24.13 — having risen by just 60p from April 2025 in a below-inflation increase that the profession's negotiating body publicly described as derisory. The Optometric Fees Negotiating Committee has stated that the NHS pays less than 50% of the actual cost of delivering a GOS sight test.
The argument that optometrists should collectively refuse NHS remuneration at its current rate is one that the profession has debated at various points and has not acted on. Whether organised collective action on NHS fees is the right lever, or whether the answer lies in structural reform of the model itself, is a question the profession has not yet resolved. What is clear is that the current arrangement — NHS examinations cross-subsidised by the retail sale of spectacles, with the NHS fee held artificially low because the retail transaction is assumed to follow — is a model that serves the NHS more than it serves independent practitioners or patients.
The market is already starting to break apart — from the dispensing side.
Here is what is easy to miss in this debate. While the conversation about standalone optometric examination practice remains largely theoretical, the separation is already beginning to happen in practice — and it is happening from the other direction. Dispensing-only practices, operating without any eye testing function whatsoever, are appearing on UK high streets. And one of them is growing fast enough to have caught the attention of three Dragons.
Pop Specs was founded in 2020 by Daniel Barnes and Lina Tejoprayitno, both optical industry professionals. The model is straightforward: no sight testing, no optometrist on site. Patients bring a valid prescription, choose their frames, and leave with fitted glasses in under twenty minutes. The business has sold over 250,000 pairs of glasses and now operates over 30 locations across the UK — including Meadowhall, Manchester Arndale, the Trafford Centre, and Trinity Leeds — and is expanding further. In January 2024, it secured investment on Dragons' Den from Peter Jones, Touker Suleyman and Sara Davies, which accelerated a franchise-led rollout.
The reason Daniel Barnes started the business is worth quoting directly. After two decades in optics, he said, "I was growing more and more frustrated with the direction the industry was going. The big high street brands seem to be focused on dragging customers in with offers and then upselling, whilst the online retailers fall behind in being able to offer bespoke advice to each customer." That is not the language of a retailer spotting a market gap. It is the language of a professional who decided the existing model wasn't working—and built something different.
This is not an isolated experiment. It is an early and growing signal that experienced optical professionals — dispensing opticians and optical assistants who have spent careers within the combined examination-and-retail model — are beginning to act on the question this article raises. The dispensing function can operate independently of the commercial operation. Pop Specs is demonstrating that at scale.
There is a regulatory and legal underpinning to this that warrants a clear statement. The High Court confirmed in the late 1990s — through decisions in the Leightons and Eye-Tech cases — that dispensing is a legally distinct supply from the sale of frames and lenses. And the College of Optometrists' own guidance states explicitly that the sale and supply of spectacles must not be a condition for performing an eye examination or sight test. The legal architecture for separation already exists in both directions. Practitioners are now beginning to act on it.
One important caveat before we go further. Pop Specs operates as a franchise. For readers of this publication, that distinction matters. A franchise model trades independence for a proven system, brand infrastructure, and ongoing fees — a different proposition entirely from building something genuinely your own. We have written separately about the difference between an optical franchise and a truly independent dispensing studio — and it is worth reading alongside this piece. The point here is not that Pop Specs is the model to follow. It is that Pop Specs proves the commercial concept works. What an independent dispensing practitioner does with that proof of concept is a different question entirely — and one where independence, not franchise, should be the answer.
For dispensing opticians and experienced optical assistants, this matters directly. For most adult patients who are not in a restricted group — children under 16 and those registered as sight-impaired — the Opticians Act does not require a registered professional to make the sale of spectacles. That is why online retailers and bring-your-own-prescription models operate lawfully. For restricted groups, a registered dispensing optician or optometrist is required. Either way, the legal barrier to a standalone dispensing model is lower than most practitioners assume — the qualification the profession holds is the asset, even if it is not always the legal requirement. The barrier to operating independently is not clinical or legal. It is a cultural assumption that dispensing takes place in the same building as the examination. That assumption is cracking. And the evidence that a dispensing-only practice can work commercially — without sight testing, without the combined model, without a corporate group behind it — is now in plain sight on UK high streets.
The questions are worth sitting with.
This is not a manifesto. It is a provocation — and deliberately so, because this conversation is overdue. The separation of clinical eye examination from optical retail is not a fringe idea. It is a structural question about how a healthcare profession should be organised and remunerated, and the fact that it has not been seriously debated at scale in the UK says more about inertia than about the merits of the argument.
Maybe the answer is that the current combined model, with reform, is the right one. Maybe the standalone clinical model works for some practitioners and markets and not others. Maybe separation creates access problems that outweigh the professional benefits. These are legitimate counter-arguments. But they need to be tested against the alternative, which is a profession in which optometrists and dispensing opticians continue to deliver clinical services at fees the profession itself describes as less than 50% of cost, in a retail environment designed around spectacle sales rather than eye health, with no serious public debate about whether that is the right model for patients or practitioners.
The dental profession did not engineer a collective walkout overnight. The NHS dental crisis has been building for decades, driven by the slow, steady exit of practitioners from a system that stopped working for them. Optometry is not there yet. But the direction of travel — below-inflation fee settlements, retail margin pressure, corporate consolidation, workforce strain — is not ambiguous.
The practical and regulatory barriers to a standalone, retail-free optometric practice model in the UK are real. But so is this: the Opticians Act separates testing sight from supplying appliances as distinct activities. The clinical skills exist. The specialist services exist. The patient demand exists. What is largely missing is the permission — not legal permission, but professional and cultural permission — to seriously consider that the current structure is not the only structure.
That debate needs to happen. For optometrists. For dispensing opticians, who are caught in the same structural trap, delivering clinical expertise inside a retail model that was not designed around them, either. And for patients, who deserve a primary eye care system organised around their clinical needs rather than around the commercial requirements of spectacle retail.
We are not saying break it. We are saying: look at it. Question it. Argue in public. Because right now the argument is only happening in whispers.
That conversation starts here.
2 comments
Interesting concept. I know there is a guy, optometrist Dr Christian French, who provides an examination-only service.
Lovely the idea of a eye exam practice. Pure clinical. No retail. Hand prescriptions over like a doctor and let the patient choose where to get eyewear. Separate the retail fashion from the eye health examination. Yes, please keep refraction as part of the eye health examination, but separate it from retail. I think if this did happen, optometry would have more respect from both the public and other medical practitioners, who see optometrists, by and large, as glorified salespeople providing eye health checks.